Device Trial Radar · NCT06305481
Glaucoma Evaluation With the P200TE
Last checked: Nov 19, 2026Latest source record: Feb 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
53
Actual
Start
Feb 13, 2024
Primary completion
Oct 23, 2024
Study completion Oct 23, 2024
Sponsor
- Lead sponsor
- Optos, PLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 12, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Images captured on the P200TE device on glaucoma patients
Conditions
- Glaucoma
Interventions
P200TEDevice
SLO and OCT imaging
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of images collectedTime frame: 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Werner Optometry
Cajon, California
Specialty Eyecare Centre
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.